Kabir Mody
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 39
- Pancreatic and Hepatic Oncology Research 20
- Colorectal Cancer Treatments and Studies 8
- Lung Cancer Research Studies 7
- Cancer Immunotherapy and Biomarkers 7
-
- Cancer Genomics and Diagnostics 16
- Co-authors
- William Adam Hammond (2 shared papers)Abhisek Swaika (1 shared paper)Tanios S. Bekaii-Saab (17 shared papers)Mitesh J. Borad (18 shared papers)John Andrew Stauffer (5 shared papers)Horacio J. Asbun (3 shared papers)Alessandro Coppola (2 shared papers)Phani Keerthi Surapaneni (5 shared papers)
- Journals
- Annals of Oncology (9 papers)JCO Precision Oncology (5 papers)Frontiers in Oncology (5 papers)Pancreas (3 papers)Hepatology (3 papers)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Kabir Mody
91 papers receiving 4.2k citations
Kabir Mody's Hit Papers
Peers
Comparison fields: 5 of 103
- Hepatology 1.1k
- Oncology 1.5k
- Cancer Research 767
- Pathology and Forensic Medicine 391
- Surgery 774
Countries citing papers authored by Kabir Mody
This map shows the geographic impact of Kabir Mody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kabir Mody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kabir Mody more than expected).
Fields of papers citing papers by Kabir Mody
This network shows the impact of papers produced by Kabir Mody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kabir Mody. The network helps show where Kabir Mody may publish in the future.
Co-authors
The 25 scholars most cited alongside Kabir Mody, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma Hit paper breakdown → | 2022 | 1079 |
| 2 | 2015 | 440 | |
| 3 | Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma Hit paper breakdown → | 2024 | 229 |
| 4 | 2019 | 197 | |
| 5 | 2020 | 163 | |
| 6 | 2019 | 137 | |
| 7 | 2016 | 128 | |
| 8 | 2022 | 111 | |
| 9 | 2018 | 89 | |
| 10 | 2019 | 84 | |
| 11 | 2014 | 77 | |
| 12 | 2019 | 71 | |
| 13 | 2018 | 68 | |
| 14 | 2016 | 60 | |
| 15 | 2020 | 57 | |
| 16 | 2017 | 53 | |
| 17 | 2019 | 52 | |
| 18 | 2018 | 51 | |
| 19 | 2022 | 51 | |
| 20 | 2021 | 49 |
About Kabir Mody
Kabir Mody is a scholar working on Oncology, Cancer Research, Hepatology, Surgery and Pathology and Forensic Medicine, having authored 91 papers that have together received 4.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (20 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (20 papers), Cancer Genomics and Diagnostics (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Colorectal Cancer Treatments and Studies (8 papers), Lung Cancer Research Studies (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Neuroendocrine Tumor Research Advances (7 papers). The work is most often cited by research in Hepatology (1.1k citations), Oncology (1.5k citations), Cancer Research (767 citations), Pathology and Forensic Medicine (391 citations) and Surgery (774 citations). Kabir Mody has collaborated with scholars based in United States, France and Australia. Frequent co-authors include William Adam Hammond, Abhisek Swaika, Tanios S. Bekaii-Saab, Mitesh J. Borad, John Andrew Stauffer, Horacio J. Asbun, Alessandro Coppola, Phani Keerthi Surapaneni, Daniel H. Ahn and Mohamad Bassam Sonbol. Their work appears in journals such as Annals of Oncology, JCO Precision Oncology, Frontiers in Oncology, Pancreas and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.